SCHEMBL25838160

SCHEMBL25838160

CC(=O)c1ccc(N=O)cc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.43
MAOA P21397 2/20 0.41
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
DGAT1 O75907 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NSD2 O96028 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
MCL1 Q07820 1/20 0.34
SNCA P37840 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25838145 0.82 ALB (0.42) CES2CES1DGAT1ALDH1A1KDM4E
SCHEMBL25838143 0.76 CA12 (0.47) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL11570 0.75 CES2 (0.68) MAOBMAOACES2CES1KMT2A
SCHEMBL29372550 0.75 CES2 (0.68) MAOBMAOACES2CES1KMT2A
SCHEMBL13071683 0.74 MEN1 (0.50) MAOBMAOAALDH1A1CYP3A4HPGD
SCHEMBL310878 0.74 MAOB (0.50) MAOBMAOACES2CES1ALDH1A1
SCHEMBL29799863 0.74 MAOB (0.50) MAOBMAOACES2CES1ALDH1A1
SCHEMBL1226712 0.74 KMT2A (0.46) MAOBMAOACES2CES1ALDH1A1
SCHEMBL29688899 0.74 KMT2A (0.46) MAOBMAOACES2CES1ALDH1A1
SCHEMBL6562864 0.74 MAOB (0.46) MAOBMAOACES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226228-A1 POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226228-A1 POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION TLR5, SLC10A2, FNTB MAOB 188/4885MAOA 1602/4885CES2 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.